BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 22237022)

  • 1. A novel retinoblastoma therapy from genomic and epigenetic analyses.
    Zhang J; Benavente CA; McEvoy J; Flores-Otero J; Ding L; Chen X; Ulyanov A; Wu G; Wilson M; Wang J; Brennan R; Rusch M; Manning AL; Ma J; Easton J; Shurtleff S; Mullighan C; Pounds S; Mukatira S; Gupta P; Neale G; Zhao D; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Naeve C; Dyson NJ; Mardis ER; Bahrami A; Ellison D; Wilson RK; Downing JR; Dyer MA
    Nature; 2012 Jan; 481(7381):329-34. PubMed ID: 22237022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RB1 gene inactivation by chromothripsis in human retinoblastoma.
    McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
    Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
    Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
    Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-species genomic and epigenomic landscape of retinoblastoma.
    Benavente CA; McEvoy JD; Finkelstein D; Wei L; Kang G; Wang YD; Neale G; Ragsdale S; Valentine V; Bahrami A; Temirov J; Pounds S; Zhang J; Dyer MA
    Oncotarget; 2013 Jun; 4(6):844-59. PubMed ID: 23765217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and epigenetics of human retinoblastoma.
    Benavente CA; Dyer MA
    Annu Rev Pathol; 2015; 10():547-62. PubMed ID: 25621664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course gene profiling and networks in demethylated retinoblastoma cell line.
    Malusa F; Taranta M; Zaki N; Cinti C; Capobianco E
    Oncotarget; 2015 Sep; 6(27):23688-707. PubMed ID: 26143641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
    Pappas L; Xu XL; Abramson DH; Jhanwar SC
    Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.
    Pritchard EM; Stewart E; Zhu F; Bradley C; Griffiths L; Yang L; Suryadevara PK; Zhang J; Freeman BB; Guy RK; Dyer MA
    Pharm Res; 2014 Nov; 31(11):3060-72. PubMed ID: 24906597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.
    Pritchard EM; Dyer MA; Guy RK
    Mini Rev Med Chem; 2016; 16(6):430-54. PubMed ID: 26202204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYK is a target of lymphocyte-derived microparticles in the induction of apoptosis of human retinoblastoma cells.
    Qiu Q; Yang C; Xiong W; Tahiri H; Payeur M; Superstein R; Carret AS; Hamel P; Ellezam B; Martin B; Vezina M; Sapieha P; Liu G; Hardy P
    Apoptosis; 2015 Dec; 20(12):1613-22. PubMed ID: 26404525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and Molecular Diagnostics in Retinoblastoma--An Update.
    Soliman SE; Racher H; Zhang C; MacDonald H; Gallie BL
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):197-207. PubMed ID: 28399338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion.
    Dehainault C; Garancher A; Castéra L; Cassoux N; Aerts I; Doz F; Desjardins L; Lumbroso L; Montes de Oca R; Almouzni G; Stoppa-Lyonnet D; Pouponnot C; Gauthier-Villars M; Houdayer C
    Hum Mol Genet; 2014 Oct; 23(19):5243-50. PubMed ID: 24858910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma from human stem cell-derived retinal organoids.
    Norrie JL; Nityanandam A; Lai K; Chen X; Wilson M; Stewart E; Griffiths L; Jin H; Wu G; Orr B; Tran Q; Allen S; Reilly C; Zhou X; Zhang J; Newman K; Johnson D; Brennan R; Dyer MA
    Nat Commun; 2021 Jul; 12(1):4535. PubMed ID: 34315877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and Epigenetic Discoveries in Human Retinoblastoma.
    McEvoy JD; Dyer MA
    Crit Rev Oncog; 2015; 20(3-4):217-25. PubMed ID: 26349417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the
    Raizis AM; Racher HM; Foucal A; Dimaras H; Gallie BL; George PM
    Epigenetics; 2021 Sep; 16(9):940-954. PubMed ID: 33258708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rb1 gene inhibits the viability of retinoblastoma cells by regulating homologous recombination.
    Yang Y; Tian S; Brown B; Chen P; Hu H; Xia L; Zhang J; Cai X; Chen Z; Pan X; Ge J; Yu K; Zhuang J
    Int J Mol Med; 2013 Jul; 32(1):137-43. PubMed ID: 23670186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
    Kooi IE; Mol BM; Moll AC; van der Valk P; de Jong MC; de Graaf P; van Mil SE; Schouten-van Meeteren AY; Meijers-Heijboer H; Kaspers GL; Te Riele H; Cloos J; Dorsman JC
    EBioMedicine; 2015 Jul; 2(7):660-70. PubMed ID: 26288838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon RB1 somatic mutations in a unilateral retinoblastoma patient.
    Ottaviani D; Alonso C; Szijan I
    Medicina (B Aires); 2015; 75(3):137-41. PubMed ID: 26117602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the p53 pathway in retinoblastoma.
    Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
    Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing.
    Ferres-Marco D; Gutierrez-Garcia I; Vallejo DM; Bolivar J; Gutierrez-Aviño FJ; Dominguez M
    Nature; 2006 Jan; 439(7075):430-6. PubMed ID: 16437107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.